FormBlends is a telehealth weight loss clinic that prescribes
compounded semaglutide and tirzepatide to patients across the
United States. If you’ve looked into Ozempic or Mounjaro and
couldn’t justify the $1,000 to $1,600 monthly cost, compounded
versions use the same active ingredients at a fraction of
the price.

Semaglutide programs start at $149/month. Tirzepatide programs
start at $299/month. No insurance required. No office visit.
The process is fully online: you complete a health
questionnaire, consult with a licensed physician via
telehealth, and your medication ships to your door within
3 to 5 business days. Everything is physician-supervised
throughout, with dosing adjusted as you progress.

Semaglutide works by mimicking the GLP-1 hormone to slow
digestion and reduce appetite, starting at 0.25mg weekly
and increasing gradually to 2.4mg. Tirzepatide targets both
GLP-1 and GIP receptors, making it a dual-agonist. Clinical
trials showed average weight loss of 14.9% with semaglutide
and up to 22.5% with tirzepatide over 68 weeks. Individual
results vary. Treatment requires a physician consultation.

FormBlends also carries recovery peptides: BPC-157 for gut
and joint health, and TB-500 for tissue repair, popular with
athletes alongside their weight loss programs.

Compounded medications are sourced from FDA-regulated 503B
outsourcing pharmacies. No hidden fees. No subscription
traps. Transparent pricing from start to finish

Additional Info

Founder(s)Bill Dean
CEO/PresidentPresident
Current ARR-1
Bootstrapped or Raised?Bootstrapped
Team Size-3
Year Founded2022
Funding1
Company TaglineFormBlend
HiringNo